Oral Answers to Questions Debate

Full Debate: Read Full Debate
Department: HM Treasury

Oral Answers to Questions

George Freeman Excerpts
Tuesday 25th June 2013

(10 years, 10 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Sheryll Murray Portrait Sheryll Murray (South East Cornwall) (Con)
- Hansard - - - Excerpts

3. What recent fiscal steps he has taken to support small businesses.

George Freeman Portrait George Freeman (Mid Norfolk) (Con)
- Hansard - -

8. What recent fiscal steps he has taken to support small businesses.

--- Later in debate ---
George Osborne Portrait Mr Osborne
- Hansard - - - Excerpts

I thank my hon. Friend for her work on the Finance Bill, which she put huge effort into. I know she is passionate about her constituents and the businesses of Cornwall. The Department for Environment, Food and Rural Affairs has already given £7 million in rural development grants to her constituency. She has raised some specific cases; a company that makes Cornish Blue has been waiting for what I think is an unacceptable period for an answer from another Government Department about a grant. I will personally look into this matter and see if we can speed the award.

George Freeman Portrait George Freeman
- Hansard - -

In the £50 billion UK life science industry, the Chancellor’s support for the patent box, the research and development tax credits and a globally competitive corporation tax rate are helping to secure global companies here, as evidenced by Johnson & Johnson’s recent announcement of a global innovation centre here in the UK. Does he also agree that we need to support insurgent small and medium-sized enterprises emerging into the sector? I would like to highlight the role of the biomedical catalyst fund in securing over 50 projects for the UK and £1 billion in venture capital funding.

George Osborne Portrait Mr Osborne
- Hansard - - - Excerpts

My hon. Friend’s knowledge in this area is well known, and he has applied it as a Member of Parliament to promoting schemes that help the life sciences industry—and not just the big companies, although we welcome the Johnson & Johnson announcement, but the small companies, too. The biomedical catalyst fund has been very successful at supporting small businesses in this sector. Without giving too much away about tomorrow’s announcements, I can tell him that we will go on funding this scheme.